Screener
Praxis Precision Medicines, Inc. PRAX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 492 | 147 |
| Operating lease right-of-use assets | 1,001 | 92 |
| Internal-use software | 773 | — |
| Other assets | 643 | — |
| Total assets | $1,390,102 | $937,907 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $23,386 | $24,628 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s deferred tax assets and other non-current assets?
- Praxis Precision Medicines, Inc. (PRAX) reported deferred tax assets and other non-current assets of $643K in Q2 2026.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s deferred tax assets and other non-current assets has grown at a -100.0% compound annual growth rate (CAGR), from $15K to $0.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Praxis Precision Medicines, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude